Witte, D.; Zeeh, F.; Gädeken, T.; Gieseler, F.; Rauch, B.H.; Settmacher, U.; Kaufmann, R.; Lehnert, H.; Ungefroren, H.
Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer. J. Clin. Med. 2016, 5, 111.
https://doi.org/10.3390/jcm5120111
AMA Style
Witte D, Zeeh F, Gädeken T, Gieseler F, Rauch BH, Settmacher U, Kaufmann R, Lehnert H, Ungefroren H.
Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer. Journal of Clinical Medicine. 2016; 5(12):111.
https://doi.org/10.3390/jcm5120111
Chicago/Turabian Style
Witte, David, Franziska Zeeh, Thomas Gädeken, Frank Gieseler, Bernhard H. Rauch, Utz Settmacher, Roland Kaufmann, Hendrik Lehnert, and Hendrik Ungefroren.
2016. "Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer" Journal of Clinical Medicine 5, no. 12: 111.
https://doi.org/10.3390/jcm5120111
APA Style
Witte, D., Zeeh, F., Gädeken, T., Gieseler, F., Rauch, B. H., Settmacher, U., Kaufmann, R., Lehnert, H., & Ungefroren, H.
(2016). Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer. Journal of Clinical Medicine, 5(12), 111.
https://doi.org/10.3390/jcm5120111